Events Press Releases Investor Home Investor Resources Corporate Presentation> Stock Information> SEC Filings> Analyst Coverage> Investor FAQ> Corporate Governance> Committee> IR Home> Crinetics Presents Data from Phase 2 Study of Paltusotine in Carcinoid Syndrome Mar 12, 2024 at 4:30 PM EDT Live and Archived Webcast Supporting Materials Pal CS Ph2 Investor Deck_FINAL_3-12-24_Upload.pdf 1 MB Email Alerts RSS Feeds Print Email Page Events Press Releases Investor Home Contact Press Releases & Events> Financial Alerts> Media Inquiries> Contact IR> Required fields denoted by an asterisk (). Alert type Quote SEC Filing Weekly Summary Email Leave this field blank First Name Last Name Email Organization Message Leave this field blank Contact Press Releases & Events> Financial Alerts> Required fields denoted by an asterisk (). Alert type Quote SEC Filing Weekly Summary Email Leave this field blank Media Inquiries> Contact IR> First Name Last Name Email Organization Message Leave this field blank
Crinetics Presents Data from Phase 2 Study of Paltusotine in Carcinoid Syndrome Mar 12, 2024 at 4:30 PM EDT Live and Archived Webcast Supporting Materials Pal CS Ph2 Investor Deck_FINAL_3-12-24_Upload.pdf 1 MB